Drug intelligence / Profile preview

Winning Body Sheng Gu Fang

Development stage: Preclinical
Administration: Oral (presumed)

Overview

Winning Body Sheng Gu Fang is a Traditional Chinese Medicine (TCM) intervention currently under investigation in clinical trials for the treatment of sarcopenia-osteoporosis. It is being studied as part of a combined therapy approach, integrating with conventional drug treatments, physical factors, and rehabilitation training. As a TCM formula, its specific composition and detailed molecular mechanisms of action are not publicly disclosed, but it is generally understood to aim at improving muscle mass, enhancing strength, and promoting bone health, consistent with TCM principles for musculoskeletal disorders.

Other names: 赢体生骨方

Beyond the preview

Go deeper on Winning Body Sheng Gu Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Winning Body Sheng Gu Fang.

Explore the full profile